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Construction and in vitro analysis of a new bi-modular polypeptide
synthetase for synthesis of N-methylated acyl peptides
Florian Schauwecker, Frank Pfennig, Nicolas Grammel and Ullrich Keller
Background: Many active peptides are synthesized by nonribosomal peptide
synthetases (NRPSs), large multimodular enzymes. Each module incorporates
one amino acid, and is composed of two domains: an activation domain that
activates the substrate amino acid and a condensation domain for peptide-bond
formation. Activation domains sometimes contain additional activities
(e.g. N-methylation or epimerization). Novel peptides can be generated by
swapping domains. Exchange of domains containing N-methylation activity has
not been reported, however. 
Results: The actinomycin NRPS was used to investigate domain swapping. The
first two amino acids of actinomycin are threonine and valine. We replaced the
valine activation domain of module 2 with an N-methyl valine (MeVal) activation
domain. The recombinant NRPS (AcmTmVe) catalyzes the formation of
threonyl—valine. In the presence of S-adenosyl-methionine, valine was converted
to MeVal but subsequent dipeptide formation was blocked. When acyl-threonine
(the natural intermediate) was present at module 1, formation of acyl-threonine–
MeVal occurred. The epimerization domain of AcmTmVe was impaired.
Conclusions: A simple activation domain can be replaced by one with
N-methylation activity. The same condensation domain can catalyze peptide-
bond formation between N-methyl and nonmethylated amino acids.
Modification of the upstream amino acid (i.e. acylation of threonine), however,
was required for condensation with MeVal. Steric hindrance reduces chemical
reactivity of N-methyl amino acids — perfect substrate positioning may only be
achieved with acylated threonine. Loss of the epimerase activity of AcmTmVe
suggests N-methyltransferase and epimerase domains, not found together
naturally, are incompatible.
Introduction
Many pharmacologically important, low-molecular weight
peptides are synthesized nonribosomally by nonribosomal
peptide synthetases (NRPSs), large, multifunctional
protein complexes. NRPSs are composed of highly con-
served repeating units (modules) each with an average
size of 120 kDa [1–6]. Each module catalyzes the incorpo-
ration of one specific substrate amino acid into the final
peptide. The different catalytic activities of a single
module can be assigned to distinct domains arranged in
the following order. Firstly, the condensation domain,
necessary for peptide-bond formation between the
growing peptide chain and the substrate amino acid; sec-
ondly, the adenylation domain, necessary for recognition
and adenylation of the substrate amino acid, and thirdly,
the thiolation domain, required for covalently binding the
substrate amino acid via a 4′-phosphopantetheine cofactor.
Together, the adenylation and thiolation domains form an
activation domain, which is the minimal NRPS unit
capable of initiating peptide synthesis. A module might
also contain accessory domains such as an epimerization
domain, located carboxy-terminal to the activation
domain, that catalyzes epimerization of the substrate
amino acid. In some of these extended modules, the sub-
strate amino acid is epimerized after the condensation
step. N-methyltransferase domains, which are located
between the adenylation and thiolation domains, can cat-
alyze N-methylation of the amino acid bound to the thiola-
tion domain. Domains with homology to thioesterases,
catalyzing release of peptide chains from NRPS, are found
in the carboxyl-terminal region of some NRPSs. The
number and sequential arrangement of modules in an
NRPS determine the sequence and number of amino
acids in the peptide formed by that NRPS.
Early enzymatic studies on the biosynthesis of the
chromopentapeptide lactone antibiotic actinomycin [7]
showed that some NRPS systems also involve autonomous
domains such as the 4-methyl-3-hydroxy-anthranilic acid
(4-MHA)-adenylating enzyme (ACMS I), which is an
independent adenylation domain. This enzyme was the
first of a number of similar adenylating enzymes later
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found to operate in the biosyntheses of mikamycins,
quinoxaline antibiotics, enterobactin and yersiniabactin
[8–11]. These enzymes load their aromatic substrates onto
specific thiolation domains, which are either fused to other
proteins or exist as autonomous units similar in structure to
the small acyl carrier proteins (ACPs) of some fatty acyl
synthases and type II polyketide synthases (PKSs). The
presence of enzymes that represent single domains in
modular systems indicates that NRPS modules might have
arisen from gene fusions of initially autonomous domains.
This postulated system of domain fusion and switching
may be the natural precedent of current engineering
strategies to construct new enzymes using combinatorial
approaches. The actinomycin synthetase system (Figure 1)
combines nearly all features of nonribosomal systems,
which can be used for anticipated domain shuffling. It has
an adenylating enzyme (ACMS I) responsible for activa-
tion of the starter residue 4-MHA, a small 4-MHA carrier
enzyme (AcmACP) and two modular NRPSs, called actin-
omycin synthetase (ACMS) II and III, that consist of two
and three modules, respectively, responsible for assembly
of the five amino acids of the peptide lactone rings of
actinomycin. This enzyme system synthesizes 4-MHA
pentapeptide lactones, which in turn become converted to
actinomycin in the presence of oxygen. The genes of
ACMS I, AcmACP and ACMS II were previously identi-
fied by cloning and analyzing the actinomycin (acm) gene
cluster from Streptomyces chrysomallus [12,13]. As shown
here, the sequence analyses of the ACMS III gene (acmC)
revealed, as expected, that ACMS III consists of three
modules. The last two modules each possess an N-methyl-
transferase domain, which is consistent with the fact that
the last two amino acids in the pentapeptide chain are
N-methylated (sarcosine, Sar, and N-methyl-valine,
MeVal, respectively). Interestingly, the three substrate
amino acids (proline, glycine and valine), each activated as
288 Chemistry & Biology 2000, Vol 7 No 4
Figure 1
Synthesis of the actinomycin pentapeptide lactone in Streptomyces
chrysomallus. (a) The genomic arrangement of the four genes,
coding for the enzymes AcmACP and ACMS I–III, is shown at the
top. The encoded enzymes catalyze the ATP-dependent,
nonribosomal synthesis of the aryl pentapeptide from substrates
4-MHA (4-methyl-3-hydroxy-anthranilic acid), threonine, valine,
proline, glycine and S-adenosyl-methionine (SAM) as indicated.
(b) 4-MHA is first adenylated by ACMS I, bound by AcmACP and
stepwise condensed with the amino acids residing at the activation
domains of NRPSs ACMS II and III. Glycine and valine are
N-methylated prior to condensation (MeVal, N-methyl-valine;
Sar, sarcosine). The NRPS activation domains, the thioesterase-like
domain (T) and the epimerization domain (E) are shown as thick
blocks and the NRPS condensation domains shown as slender
blocks. The 4′-phosphopantetheine co-factors for covalent substrate
binding are indicated on top of the domains. The dotted line
indicates that epimerization of valine to D-Val occurs only after
formation of the aryl-dipeptide.
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its thioester by ACMS III, are finally condensed in the
form of an imino acid (proline, Sar and MeVal), whereas
the modules of ACMS II exclusively condense α-amino
acids (threonine and valine). In view of recent reports con-
cerning the specificity of condensation domains, which
discriminate between various substrates [14,15], we asked
whether the condensation domains of ACMS II are spe-
cific for α-amino acids or whether they also condense
N-methyl amino acids. Moreover, from primary sequence
comparisons of numerous condensation domains, a system
for determining the specificity of condensation domains
was recently postulated [16]. We therefore designed
experiments to exchange the valine activation domain of
ACMS II for the MeVal activation domain of ACMS III
and to test the resulting enzyme for its ability to catalyze
the formation of N-methylated peptides. If successful,
these experiments would answer the question of whether
activation domains with N-methyltransferase activity can
replace minimal activation domains in foreign NRPSs.
Moreover, by using ACMS II as a scaffold, the experiment
would also determine whether such elongated activation
domains are compatible with an adjacent epimerase
domain. To date, no NRPS gene is known to code for this
kind of domain arrangement.
Results
Sequencing the gene of ACMS III (acmC)
As reported previously, we located the ACMS III gene
(acmC) immediately downstream of the ACMS II gene
(acmB) in the acm gene cluster of S. chrysomallus [12].
Sequencing this region revealed that acmC is 12,744 bp,
has a start codon overlapping the stop codon of acmB and
codes for a deduced protein of 462 kDa. This is consistent
with the determined size of 480 kDa for ACMS III [17].
The analysis of the deduced amino acid (aa) sequence
revealed the presence of three amino acid activation
domains (aa 426–1051, 1488–2525 and 2964–3983), each
with an accompanying, upstream condensation domain. In
the last two modules, the adenylation and thiolation
domains are separated by an N-methyltransferase domain
(aa 1978–2391 and 3444–3849), similar to those found in
related activation domains of the cyclosporine (CysA),
enniatin (ESYN) and pristinamycin I (SNBD) synthetases
[18–20], which also catalyze N-methylation of substrate
amino acids. According to the degree of sequence identi-
ties, the various known N-methyltransferase domains of
NRPSs can be classified into those of bacterial origin
(ACMS III and SNBD; three domains) and those of fungal
origin (CysA and ESYN; eight domains). Sequence identi-
ties of N-methyltransferase domains are 41–69% within
each group but range only between 21–27% when bacter-
ial and fungal sequences are compared. Another recently
identified N-methyltransferase domain of a microcystin
NRPS from Microcystis aeruginosa [21] shares 31–34% and
21–23% identity to the other bacterial and fungal
sequences, respectively. A thioesterase-like domain was
identified in the carboxy-terminal part of ACMS III (the
typical GxSxG motif at aa 4066), probably used for
release/cyclization of the synthesized peptide lactone.
Construction and heterologous gene expression of
engineered ACMS II derivatives
The set of five different activation domains (threonine,
valine, proline, Sar, and MeVal) of the ACMS system pro-
vides a collection of functionally compatible modules for
combinatorial in vitro experiments. The in vivo and in vitro
catalytic activity of the two-modular ACMS II (threonine
and valine) is well characterized [12,22,23]. We therefore
used this NRPS as a scaffold to investigate whether a con-
densation domain, which naturally catalyzes peptide-bond
formation between nonmethylated amino acids, can also
condense N-methylated substrates and whether a N-
methyl amino acid activation domain is compatible with
the other domains present in this scaffold. To address this
question, we replaced the ACMS II valine domain with
the MeVal domain of ACMS III. As both domains can
activate valine, possible differences in the catalytic activ-
ity of the chimeric protein should only result from the
presence of the additional N-methylation domain or the
altered reactivity of N-methyl-valine compared with that
of valine. To swap the valine domain of ACMS II
(Figure 2) we used a natural ClaI site at basepair (bp) 4519
in the ACMS II gene (acmB). This region contains a less
conserved amino acid motif that is found at the borders
between the carboxy-terminal ends of the condensation
domains and the downstream activation domains (see the
Materials and methods section). In fact, the amino termini
of some NRPSs, which lack an amino-terminal condensa-
tion domain (e.g. GrsA, PhsA, TycA or BacA) [24–27],
map very closely to this border. To create a suitable fusion
point at the carboxy-terminal end of the valine domain,
we introduced an EcoRV site in acmB at bp 6250, which
corresponds to a position 20 amino acids carboxy-terminal
to the serine of the 4′-phosphopantetheine binding site in
the thiolation domain. As this fusion point is still located
within the highly conserved carboxy-terminal end of the
thiolation domains, the border to the downstream ACMS
II epimerase domain remained unchanged after domain
swapping. The region in acmB between ClaI and EcoRV
was then replaced by a polymerase chain reaction (PCR)-
generated 2.9 kb ClaI–EcoRV fragment obtained from
acmC. This PCR fragment codes for the MeVal domain of
ACMS III, and the restriction sites were introduced in a
manner that exactly fitted the fusion points described for
ACMS II (see the Materials and methods section). To
compare this new enzyme (AcmTmVe; 330 kDa) with
appropriate controls, we constructed an ACMS II deriva-
tive with a swapped MeVal domain in a similar manner,
but the epimerase domain was deleted (AcmTmV;
260 kDa). We also back-constructed ACMS II by inserting
the original valine domain, using the fusion points
described above (AcmTVe; 280 kDa). We performed this
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control to verify that the amino acid changes to the ACMS
II sequence did not disturb catalytic activity and that the
scaffold, which was partially assembled from PCR gener-
ated fragments, encodes a functional NRPS. The NRPS
genes were then heterologously expressed in Streptomyces
lividans under the control of the melanin promotor on
pIJ702 derivatives, as previously described for heterolo-
gous expression of the ACMS II gene [12]. Proteins of the
expected sizes were detected using sodium dodecylsul-
phate–polyacrylamide gel electrophoresis (SDS–PAGE)
(Figure 2) and the enzymes were partially purified for
further enzymatic studies.
In vitro formation of an N-methylated acyl dipeptide after co-
incubation of engineered NRPS with ACMS I and AcmACP
The aromatic precursor 4-MHA in actinomycin biosynthe-
sis is first adenylated by ACMS I, then bound by AcmACP
and finally condensed with the threonine bound at the
threonine domain of ACMS II. With p-toluic acid as the
precursor (which can replace the natural but highly oxida-
tion sensitive 4-MHA), ACMS II can catalyze the in vitro
formation of p-toluyl-Thr–L-Val and p-toluyl-Thr–D-Val
[22,23]. Because ACMS II lacks a thioesterase domain,
products or intermediates are not released from the
enzyme in vitro but remain covalently bound through a
thioester linkage. They can, however, be analyzed after
chemical thioester cleavage and extraction, as described in
the Materials and methods section. Accordingly, the prod-
ucts formed by the engineered NRPS were also analyzed
after co-incubation with ACMS I, AcmACP, p-toluic acid
and 14C-labelled substrate amino acids. The reactions
were performed in the presence or absence of S-adenosyl
methionine (SAM), which is the methyl group donor for
N-methylation of substrate amino acids. 
In the absence of SAM and by labelling with either
14C-p-toluic acid, 14C-Thr or 14C-Val, thin-layer chromatog-
raphy (TLC) revealed that all engineered NRPS, similar to
wild-type ACMS II, can synthesize both p-toluyl-Thr and
p-toluyl-Thr–Val (the latter shown for AcmTmVe with
14C-Val as label; compound i in Figure 3). This result was
not unexpected as the in vitro formation of nonmethylated
peptides in the absence of SAM was also reported for the
peptide synthetase ESYN, which also possesses a
N-methyltransferase domain [28]. Amino acid hydrolysis of
the formed p-toluyl-Thr–Val and analyzing the configura-
tion of valine revealed, however, that AcmTmVe did not
synthesize the expected p-toluyl-Thr–D-Val diastereomer
(data not shown). This indicated the epimerization domain
in this enzyme was not functioning properly. 
Strikingly, in the presence of SAM, when 14C-Thr or
14C-Val were used as labels two new radioactive com-
pounds were formed by the enzyme constructs
AcmTmVe and AcmTmV but not by ACMS II or
AcmTVe (shown for AcmTmVe with 14C-Val as label;
compounds ii and iii in Figure 3). From these two SAM-
dependent compounds, only ii was also labelled when
14C-p-toluic acid was used as label (data not shown).
Analysis of ii by amino acid hydrolysis revealed that
14C-Val was converted into 14C-labelled N-methyl-L-valine.
That ii was p-toluyl-Thr–MeL-Val was confirmed by
TLC and high-performance liquid chromatography
(HPLC) co-chromatography with authentic p-toluyl-
Thr–MeL-Val (Figure 3). The amino acid hydrolysis of iii
revealed that it contained MeVal in both optical configu-
rations (the ratio of MeL-Val to MeD-Val was 3:2). Com-
pound iii did not contain 14C-p-toluic acid and TLC
co-chromatography with authentic cyclo-(Thr–MeVal)
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Figure 2
Construction and expression of recombinant
NRPS genes. (a) The ACMS II gene (acmB)
and 1.1 kb downstream region; important
restriction sites are indicated (S, Sst I; Cl, Cla I;
Bm, BamHI; EV, EcoRV). The region between
a natural ClaI site and a PCR-generated
EcoRV site (EV*) was replaced by PCR
fragments, coding for the valine activation
domain (Val) of ACMS II or the N-methyl-valine
activation domain (MeVal) of ACMS III. In the
construct coding for AcmTmV, the region
between a PCR-introduced Sst I site (S*) and
a natural Sst I site at the end of acmB was
deleted in order to remove the epimerization
domain. (b) The SDS–PAGE (5%; coomassie
stained) shows formation of gene products
(arrow) after heterologous gene expression in
S. lividans from the melanin promotor in
pIJ702 derivatives. Size markers were
wild-type ACMS II (280 kDa) and SDS-6H
from Sigma (205–29 kDa).
cm7402.qxd  03/22/2000  08:41  Page 290
showed that it was not identical to that diketopiperazine.
The structure of iii, therefore, remains unknown. 
The products formed by AcmTmVe in the presence of
SAM were monitored by TLC over a period of 45 minutes
(as described in the Materials and methods section). Kinetic
analysis revealed that the reaction was linear for 5 minutes
and approached saturation after 20 minutes. Interestingly,
the reaction rates of p-toluyl-Thr–Val and p-toluyl-
Thr–MeVal formation were identical, indicating that valine
and N-methyl valine are equally reactive for AcmTmVe-
catalyzed condensation with acyl-threonine. Formation of
iii showed the same time dependency but it was synthe-
sized in larger amounts. The time course of p-toluyl-
Thr–Val formation in the absence of SAM was fairly equal
to that of p-toluyl-Thr–Val formation in the presence of
SAM, but nearly double the amount was formed.
In summary, the identification of p-toluyl-Thr–MeVal
shows that the MeVal domain can function in the
ACMS II scaffold and that an N-methyl amino acid can
be condensed with p-toluyl-threonine by the ACMS II
condensation domain.
Condensation of N-methyl-valine depends on the prior
acylation of threonine
The finding that AcmTmV and AcmTmVe can both cat-
alyze formation of p-toluyl-Thr–L-Val and p-toluyl-Thr–
MeL-Val, with AcmTmVe being incapable of epimerizing
these dipeptides, prompted us to investigate the mecha-
nism of dipeptide formation in more detail. It is known
that ACMS II can also catalyze the in vitro synthesis of the
nonacylated dipeptide Thr–Val along with its diastere-
omer Thr–D-Val in the absence of p-toluic acid, ACMS I
or AcmACP [23]. AcmTmV and AcmTmVe were then
analyzed under the same conditions for their ability to
synthesize respective N-methylated dipeptides. Enzymes
were incubated with 14C-labelled substrates and products
were analyzed by TLC after thioester cleavage (shown for
AcmTmVe in Figure 4). After incubation with valine
alone, valine was released unmodified from the enzyme
but was converted into MeVal in the presence of SAM.
The MeVal formed was identified exclusively to be
MeL-Val. This was not unexpected as ACMS II catalyzes
valine epimerization only after dipeptide formation. Incu-
bation with valine in the presence of threonine, however,
yielded only the nonepimerized dipeptide Thr–L-Val. In
contrast, the ACMS II, as with the control construct
AcmTVe, retained its epimerase activity (data not shown). 
The results of the analyses of AcmTmV and AcmTmVe in
the presence of valine, threonine and SAM were remark-
able. It was observed from labelling with 14C-valine that
nearly all of the valine was converted into MeVal, but for-
mation of the expected Thr–MeL-Val was not observed.
Only a very faint signal indicated formation of only a small
amount of nonmethylated Thr–L-Val, resulting from a con-
densation reaction prior to the N-methylation of valine. To
verify the absence of Thr–MeL-Val, which would migrate
very close to Thr–L-Val in TLC, we also used 14C-SAM as
a label (Figure 4a, right panel). In the presence of valine,
the labeled methyl group of SAM was incorporated into
MeVal. No formation of N-methylated peptides was
detected after addition of threonine, which confirmed that
the MeVal was not condensed with threonine. It appears
that condensation of MeVal with threonine, catalyzed by
AcmTmVe and AcmTmV, is dependent on the prior acyla-
tion of threonine as revealed by the analyses in the pres-
ence of ACMS I and AcmACP. The results are
schematically summarized in Figures 5 and 6.
Discussion
Our previous work on the biosynthesis of N-methylated
acyl-peptide lactones with aromatic side groups, such as the
actinomycins, quinoxaline antibiotics and mikamycins, has
revealed that these compounds are synthesized by similar
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Figure 3
Formation of p-toluyl-threonyl–N-methyl-valine. (a) An autoradiogram of
TLC analysis of products formed by AcmTmVe. Products were released
from the enzyme by chemical thioester cleavage after incubation with
ACMS I, AcmACP, p-toluic acid, threonine and 14C-valine. ATP and
S-adenosyl-methionine (SAM) were added or omitted as indicated
above the lanes. Formation of p-toluyl-threonyl–14C-valine i was
dependent on ATP, formation of p-toluyl-threonyl—N-methyl-14C-valine
ii and an uncharacterized compound iii were both dependent on ATP
and SAM. (b) Labelled compounds i and ii (not UV-detectable) were
isolated from silica plates and mixed with chemically synthesized
p-toluyl-threonyl–valine and p-toluyl-threonyl–N-methyl-valine (OD
0.2–0.4 at 260 nm) for HPLC analysis as described in the Materials and
methods section. Fractions were collected and 14C-labelled compounds
were identified by liquid scintillation counting (dotted curve).
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sets of modular NRPSs that harbour additional N-methyl-
transferase and epimerase activities. NRPSs are arrays of
highly conserved modules, each ~1000–1400 amino acids in
length, and each module is responsible for the activation
and incorporation of one amino acid into the final peptide
product [1–6]. A typical NRPS module consists of an acti-
vation domain, which determines substrate specificity, and
an amino-terminally located condensation domain, which
catalyzes peptide-bond formation. Activation domains are
always separated by condensation domains in these multi-
modular NRPS arrays. 
We recently cloned the actinomycin (acm) gene cluster of
S. chrysomallus and sequenced the ACMS II gene (acmB)
[12]. This NRPS consists of two modules with activation
domains for threonine and valine, respectively, and an
epimerization domain located at the carboxy-terminal end
of the enzyme. In conjunction with the adenylating
enzyme ACMS I and the small ACP AcmACP, ACMS II
attaches threonine and valine to the aromatic starter unit
of actinomycin biosynthesis and also epimerizes valine to
form the aryl dipeptide [22,23]. The data presented here
show that the ACMS III gene (acmC) codes for the
remaining three modules required for pentapeptide
lactone ring assembly in actinomycin synthesis. These
modules are responsible for the incorporation of proline,
sarcosine and N-methyl-valine; a carboxy-terminally
located thioesterase domain might be responsible for
product release. The last two modules of ACMS III each
carry a N-methyltransferase domain inserted into their
activation domains, which is necessary for the N-methyla-
tion of glycine and valine prior to condensation. The
genetic arrangement of the encoded ACMS modules, as in
most NRPS systems, therefore dictates the sequence and
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Figure 4
Dipeptide formation and synthesis of N-methyl-valine catalyzed by
AcmTmVe. (a) Autoradiograms of TLC analyses of products
synthesized by AcmTmVe that were released from the enzyme after
chemical thioester cleavage. The enzyme was incubated with the
substrate combinations indicated at the top of the lanes in the
presence of ATP. 14C-labelled substrates are indicated by an asterisk.
In the presence of S-adenosyl-methionine (SAM), valine is converted
into N-methyl-valine and formation of N-methylated dipeptides was not
detectable with 14C-valine (left panel) nor with 14C-SAM (right panel).
(b) The configuration of the synthesized threonyl–14C-valine (not
UV-detectable) was verified to be exclusively the L-form by HPLC
co-chromatography with chemical synthesized threonyl–L-valine and
threonyl–D-valine (OD 0.3 at 205 nm) as described in the Materials
and methods section.
Figure 5
Steps in peptide synthesis catalyzed by ACMS II or AcmTmVe. The
grey region indicates the part of ACMS II that was replaced in the
construction of AcmTmVe. It differs from ACMS II only in two amino
acids at the carboxy-terminal border. NRPS substrates are indicated in
the left of the figure. Enzyme-bound products and intermediates are
shown in (a) the absence or (b) the presence of the 4-MHA-adenylating
enzyme ACMS I and the ACP AcmACP (small box), which provide the
aryl moiety for acylation of threonine when p-toluic acid is added.
Catalyzed reaction steps (e.g. condensation of threonine with valine) are
indicated by arrows. The dotted line indicates that the epimerized
dipeptide remains covalently bound to the second module; other
symbols and abbreviations are the same as in Figure 1.
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modifications of the amino acids in the synthesized
peptide product. 
The high level of conservation between NRPS modules
and the precise constant locations of activation domains
within the modules suggested that targeted alterations of
modules by swapping activation domains could create a
NRPS with altered substrate specificity. Theoretically,
this could yield a new NRPS that contains altered
modules and catalysing the incorporation of new or modi-
fied amino acids into a peptide product. Attempts to
achieve this by chromosomal gene replacement have been
reported in the cases of the mono- and tri-modular NRPS
components of the surfactin synthetase system, and the
production of new products in vivo has been demonstrated
[29–31]. Altering the specificity of the activation domain
in order to design new or modified NRPSs might,
however, be constrained by interfering with the inter-
action between the new modules because of spatial
reasons, by a change in the reactivity of the new peptidyl
intermediates, or simply by inappropriate folding of these
intermediates, which might in turn lead to undesired reac-
tions or complete loss of activity in peptide-chain elonga-
tion. Moreover, the fact that modules can contain
additional domains (e.g. for N-methylation of covalently
bound amino acids or for epimerization of reaction inter-
mediates) might provoke adverse effects in the achieve-
ment of successful new module combinations. A further
obstacle in the proper interaction of foreign modules could
lie in the correct positioning and in the substrate speci-
ficity of the condensation domains. The essential role of
the condensation domain for peptide-bond formation has
been demonstrated previously in vitro for the condensa-
tion between D-phenylalanine (activated and bound by
gramicidin synthetase I, GrsA) and proline (activated and
bound by a truncated derivative of tyrocidine synthetase
II, TycB) [15]. The amino acids, bound on the two sepa-
rate enzymes, were condensed by the amino-terminal con-
densation domain of the TycB derivative. Further analysis
with this system [14] revealed that the condensation
domain appears to discriminate between various foreign
amino acids that were introduced into the activation
domain of GrsA and TycB via chemically synthesized
aminoacyl-coenzyme A thioesters. From the same data,
however, one can also speculate that the non-natural sub-
strates, synthetically introduced into the activation
domains, are not properly juxtaposed for subsequent con-
densation by the activation domains themselves. In any
case, when designing new NRPSs, possible structural con-
straints arising from the intrinsic nature of the module or
its domains must be taken into account.
Because it was possible to express acmB as a functionally
active ACMS II in the foreign host S. lividans [12] and test
this enzyme in conjunction with its cohorts, ACMS I and
AcmACP, we decided to use this enzyme as a scaffold to
test the functional compatibility of foreign domains.
Because the ACMS III sequence is available, it was tempt-
ing to introduce an activation domain from ACMS III,
which possesses an integrated N-methyltransferase
domain, into the ACMS II scaffold. It is important to note
that, in ACMS III, all of the three modules are processing
imino acid residues (proline, Sar or MeVal) during peptide-
chain synthesis. This raises the question of whether their
condensation and activation domains are destined to inter-
act exclusively with imino acids or if they can be combined
freely with domains from modules catalyzing peptide-bond
formation between α-amino acids. Another crucial point is
that the integrated N-methyltransferase domain elongates
the activation domain for some 450 amino acids and,
hence, separates the thiolation domain from the condensa-
tion domain by that additional distance. Although it is
anticipated that the N-methyltransferase domain is orga-
nized in a globular fold, it is not clear, a priori, whether
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Figure 6
Steps in peptide synthesis catalyzed by AcmTmVe. The ACMS-
III-derived activation domain, which activates and N-methylates valine
(MeVal), is indicated by a grey bar, other symbols and abbreviations
are the same as in Figure 1. Noncatalyzed reaction steps
(e.g. condensation of threonine with MeVal) are crossed out.
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such an enlarged activation domain fits neatly into the
ACMS II scaffold and yields a fully active enzyme. Fur-
thermore, the right choice of the condensation domain
might be critical, as can be concluded from the results of
the D-Phe–Pro condensation system [14,15] described
above. In contrast to this condensation system, the two
modules in the ACMS II scaffold are on one polypeptide
chain and cannot, therefore, achieve all degrees of freedom
of their mutual interactions as two independent modules
potentially could. 
The data presented here show that the valine activation
domain in ACMS II can, in principle, be replaced by the
MeVal activation domain of ACMS III. The two engi-
neered ACMS II derivatives AcmTmVE and AcmTmV,
both containing the MeVal domain from ACMS III in
place of the Val domain, were heterologously expressed in
S. lividans at appreciable levels. The two recombinant
enzymes were efficiently modified by host 4′-phospho-
pantetheine transferases, revealed by their ability to bind
threonine and valine covalently as thioesters, and bind to
N-methylate, the thioester-bound valine, in the presence
of SAM. To test the ability of AcmTmVe and AcmTmV
to catalyze peptide-bond formation between threonine
and MeVal (or valine), two basic approaches were fol-
lowed. When the chimeric enzymes were tested in the
presence of ACMS I and AcmACP, together with p-toluic
acid as starter substrate, AcmTmVe and AcmTmV cat-
alyzed both formation of p-toluyl-Thr and p-toluyl-
Thr–Val in the same manner as ACMS II. This result
sheds some light on the spatial organisation of the N-
methyltransferase domain in module 2 or on activation
domains in general. Clearly, formation of p-toluyl-Thr and
p-toluyl-Thr–Val catalyzed by AcmTmVe or AcmTmV
proceeds as if the N-methyltransferase domain were
absent. It is further presumed that the distance of the
4′-phosphopantetheine cofactor in the second module to
the condensation domain between modules 1 and 2 is the
same as in the natural ACMS II. One has to conclude,
therefore, that the N-methyltransferase domain does not
affect the spacing between the reactive centers of cova-
lent substrate binding and that this domain might be
located peripherally to the site where the condensation
reaction between the two amino acids, thioesterified to
their carrier arms, takes place. 
In contrast to ACMS II, AcmTmVe did not catalyze
expected epimerization of p-toluyl-Thr–Val to p-toluyl-
Thr–D-Val. It has to be stressed that in the absence of
SAM the valine is not N-methylated and that this acyl
peptide is accepted as substrate for the ACMS II
epimerase domain. The observed failure of epimerization
did not result from a mutation in the epimerization
domain, which was demonstrated by reconstructing
ACMS II in the same way AcmTmVe was constructed and
using the same epimerization-domain-encoding DNA
fragment. The epimerization domain was first subcloned
and sequenced and the obtained ACMS II-like construct
AcmTVe was fully active in peptide-bond formation and
epimerization. A further crucial point in domain swapping
is in choosing the correct domain borders. The epimeriza-
tion domain was fused to the MeVal domain within the
highly conserved end of the activation domain (the fusion
point 20 amino acids carboxy-terminal to the serine in the
4′-phosphopantetheine-binding site). The adjacent vari-
able interdomain region is the same, therefore, as the
region that lies upstream of the epimerization domain in
wild-type ACMS II. This positioning ensures that this
region is as intact as possible in the recombinant enzyme.
It is important to note that in the case of the type I PKSs,
module swapping experiments have revealed a crucial role
for interdomain linkers in the assembly of functional PKS
modules [32]. The loss of epimerase activity in AcmTmVe
might, therefore, indicate that the N-methyltransferase
domain does not fit neatly into the ACMS II scaffold. The
inactivation of the epimerase domain could either result
from distortion of its structure by an unfavourable contact
with the N-methyltransferase domain or by displacement
of the epimerase domain from the radius of the 4′-phos-
phopantetheine arm in module 2, resulting from an altered
architecture of the multienzyme. From the known struc-
tures of natural, low molecular peptides, only a few
contain N-methyl amino acids in the D-configuration. As
yet, there are no NRPS sequences available showing the
implied NRPS domain arrangement in which an
epimerase domain is located carboxy-terminal to an activa-
tion domain with N-methylation activity as in AcmTmVe.
Interestingly, the NRPS genes of chloroeremomycin [33],
which belongs to the vancomycin group of antibiotics, do
not contain any integrated N-methyltransferase domains,
although vancomycins contain N-methyl-D-leucine at the
first position of their peptide backbones. Moreover, from
recent work of Pelzer et al. [34] it can be concluded that
N-methylation occurs after synthesis of the vancomycin
peptide backbone, as revealed by the analysis of interme-
diates formed by mutants impaired in steps of balhimycin
production. It remains still unclear, therefore, whether the
construct AcmTmVe represents a ‘naturally forbidden’
domain arrangement or would function, with respect to
epimerization, with domains from other NRPS systems or
in another scaffold. 
The catalytic activity of the N-methyltransferase domain
in the constructs AcmTmV and AcmTmVe was demon-
strated by their ability to form enzyme-bound MeVal from
valine in the presence of SAM. More importantly, in the
presence of SAM, the constructs also catalyzed formation
of the N-methylated aryl dipeptide p-toluyl-Thr–MeVal as
predicted. According to the above mentioned putative dis-
location of the epimerization domain, caused by the addi-
tional N-methyltransferase domain, this N-methylated aryl
dipeptide was not epimerized.
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In the second approach to test their catalyzing ability,
AcmTmVe and AcmTmV were analyzed in the absence of
ACMS I and AcmACP. Wild-type ACMS II was found to
have a relaxed specificity in the initiation reaction of
peptide lactone-ring formation in vitro. ACMS II is
unusual in that in the absence of ACMS I, AcmACP or aro-
matic carboxylic acid substrate, it can also condense threo-
nine with valine, albeit with less efficiency. The formed
dipeptide is further epimerized in vitro to its diastereomer
Thr–D-Val. Testing AcmTmVe or AcmTmV in that way
showed that both enzymes catalyzed the formation of
Thr–Val from threonine and valine. The finding that
AcmTmVE was impaired in dipeptide epimerization is
consistent with its inability to epimerize the aryl dipeptide
as described above. More surprising then was that the
additional presence of SAM had an adverse effect on
peptide-bond formation. Instead of the expected forma-
tion of Thr–MeVal, nothing happened except that the
thioester-bound valine in module 2 became N-methylated. 
Taken together these findings clearly show that the new
enzymes can condense valine with both threonine and
p-toluyl-threonine, but that the enzymes strictly distin-
guish between threonine and p-toluyl-threonine when
valine is N-methylated. The reasons for this substrate dis-
crimination are not clear. It is known that hydrolysis or
aminolysis of carboxylic acid esters is greatly favored when
there are electronegative substituents at α C due to a
minus I effect. From this, one would expect that thre-
onyl–enzyme thioester would be much more prone to
aminolysis than the p-toluyl-threonine–enzyme thioester.
The opposite was observed, however, as MeVal reacted
exclusively with p-toluyl-threonine (and not with threo-
nine). Measurements of dipeptide and p-toluyl-dipeptide
synthesis with wild-type ACMS II [22,23] have shown that
condensation between threonine and valine is more effi-
cient when threonine is first acylated with p-toluic acid.
The acylation of threonine probably triggers or enables
the optimal juxtaposition of the thioester-bound p-toluyl-
threonine in the active center of the condensation domain.
The relaxed specificity of ACMS II might be explained by
assuming that the nonacylated threonine can also be
located somehow beside or near this active center
although not optimally juxtaposed. This could be suffi-
cient for condensation with an α-amino acid residing on
module 2, but not for condensation with a N-methylated
amino acid, which is a sterically more complex reaction.
The sterical distortion, caused by the methyl group, is
thought to be the reason why in chemical peptide synthe-
sis N-methylated amino acids are less reactive in peptide-
bond formation than the related α-amino acids.
The findings presented here indicate that it is possible, in
principle, to introduce N-methyl amino acids into nonribo-
somally synthesized peptides by swapping activation
domains with integrated N-methyltransferase domains in
NRPS modules. The interference of the N-methyltrans-
ferase domain with other domains, such as epimerization
domains, has to be taken into account. Furthermore, the
substrate specificity in the peptide-bond formation
appears to be dictated by steric constraints in the upstream
module, rather than by the nature of the N-methyl amino
group itself.
Significance
Modular nonribosomal peptide synthetases (NRPSs)
can be engineered by exchanging or recombining
modules to achieve synthesis of new or altered peptides.
As presented here, substitution of the valine activation
domain in the bimodular actinomycin synthetase II by
an N-methyl valine activation domain (which contains
an additional N-methylation activity) resulted in a
NRPS that catalyzes the synthesis of both the unmethy-
lated and N-methylated acyl dipeptides. Peptide-bond
formation in this case is catalyzed by a condensation
domain, derived from the parent NRPS, that does not
distinguish between the N-methylated and nonmethy-
lated forms  of valine. In contrast, condensation of the
N-methylated valine was dependent on the substrate
amino acid of the preceding module, threonine or acyl-
threonine. Both threonine and acyl-threonine will be
condensed with valine, whereas N-methyl valine is only
condensed with acyl-threonine. One reason for this
might be that only the acylated threonine, which is the
natural intermediate, is positioned correctly for the
nucleophilic attack of N-methyl-valine. This implies that
the substrate positioning by the activation domain might
be important for peptide-bond formation, rather than an
assumed specificity of condensation domains. The
epimerase domain in this new NRPS was inactive, indi-
cating an incompatibility between an activation domain
harbouring N-methylation activity with an adjacent
epimerase domain in this NRPS scaffold. In summary,
these results show that synthesis of N-methylated pep-
tides can be achieved by swapping activation domains
within NRPS modules. 
Materials and methods
Strains and growth of organisms
Streptomyces lividans TK 64 was maintained at 30°C on R5 plates
[35]. Submerged growth took place for 3 days in 100 ml of YEME
liquid medium [35] in 300 ml flasks equipped with steel springs and
shaken at 200 rpm. S. lividans was transformed as described by
Hopwood et al. [35] and transformants were grown in the presence of
5 µg ml–1 thiostrepton.
Cloning and expression of engineered NRPS genes
For swapping the ACMS II valine activation domain, a single ClaI site
in acmB at bp position (pos) 4519 and a PCR-generated EcoRV site
at pos 6250 were used (Figure 2). The EcoRV site was generated with
primer M1, and reverse primer M2 binds downstream to an acmB
internal Sst I site (pos 7780) near the end of the gene. The PCR
product was digested with EcoRV and Sst I and the obtained 1.5 kb
fragment was subcloned for control sequencing. The end of acmB and
some acmB downstream region was added by ligating a 1.1 kb
genomic Sst I–BamHI fragment to the Sst I site of the PCR fragment.
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The obtained 2.6 kb EcoRV–BamHI fragment therefore contains the
complete 3′ region of acmB, starting from the EcoRV site at pos 6250.
The 5′ region of acmB, from the start of the gene up to the ClaI site at
pos 4519, was obtained as a 4.6 kb Pst I–ClaI fragment from pACM5
(see below). The two 5′ and 3′ regions were subsequently linked via a
1.8 kb ClaI–EcoRV fragment, encoding the Val domain of ACMS II
and amplified from acmB (pos 4519–6250) with primer M3 and M4.
This yielded the gene coding for AcmTVe. Similarly, joining the 5′ and
3′ regions via a 2.9 kb ClaI–EcoRV fragment, encoding the MeVal-
domain of ACMS III and amplified from acmC (pos 8911–11872) with
primer M5 and M6, yielded the gene encoding AcmTmVe. To delete
the epimerase domain of AcmTmVe (generating AcmTmV), a new Sst I
site (marked by an asterisk in Figure 2) was generated using PCR with
primers M7 and M8, 48 bp downstream of the EcoRV site and with the
AcmTmVe gene as template. The obtained PCR fragment spans the
EcoRV site, which was used to assemble the AcmTmV gene as
described above, and the new Sst I site was directly fused with the
natural Sst I site in acmB (bp 7780) next to the end of the gene. This
in-frame fusion deletes the epimerase domain and retains the last
18 amino acids of the carboxyl terminus unmodified. All three recombi-
nant NRPS genes were heterologously expressed in Streptomyces livi-
dans from the melanin (mel ) promotor of plasmid pIJ702 [36] as
described for the expression of acmB in the pIJ702 derivative pACM5
[12]. The start of acmB was modified to enable fusion to the mel pro-
motor by partial replacement of the pIJ702 melanin gene melC1. As
the 5′ regions of all recombinant NRPS genes were derived from
pACM5, the same fusion point to the mel promotor was achieved.
Amino acid sequences at domain borders
The amino acid sequences at the ClaI and EcoRV fusion sites (indi-
cated by slashes) or at the corresponding positions in wild-type
enzymes are: (1503)PLSRI/DVLTP and (2080)FSVRD/VFEQR for
wild-type ACMS II; (2967)PLSRI/DVLTP and (3954)LGLRS/LFEAP for
wild-type ACMS III; PLSRI/DVLTP and FSVRD/IFEQR for AcmTVe;
PLSRI/DVLTP and LGLRD/IFEQR for AcmTmVe and AcmTmV. The
fusion sequence in AcmTmV, after deletion of the ACMS II epimerase
domain (deletion of aa 2101–2594 in ACMS II) is VVAEE/LSQHD.
Protein purification and unit definition
Recombinant NRPSs were partially purified from 10 g of mycelium (wet
weight) of S. lividans transformants as previously described for
ACMS II [12]; basic steps were cell disruption by French press, DNase
I treatment, 60% ammonium sulfate precipitation and size fractionation
on Ultrogel-AcA-34 (Biosepra). In this work, Ultrogel-AcA-34 fractions
with proteins larger than 200 kDa were pooled and applied to a
Q-Sepharose-FF (Pharmacia) anion exchanger column. Bound proteins
were eluted with a step gradient of 150, 250 and 500 mM NaCl in
15% (w/v) glycerol, 100 mM Tris–HCl (pH 8), 4 mM dithiothreitol,
1 mM benzamidine. All recombinant NRPS eluted with 250 mM NaCl
and were used at this purification stage for enzymatic studies. One unit
of NRPS is the amount of enzyme that covalently binds 1 nmol of threo-
nine as determined by the thioester formation assay [12]. ACMS I and
AcmACP were isolated after heterologous expression in S. lividans
and E. coli, respectively, as described previously [13].
Isolation of reaction intermediates from NRPS
For peptide synthesis, about 0.05 units of NRPS in 0.5 ml
Q-Sepharose elution buffer (see above) were mixed with 130 µl reac-
tion mixture containing 10 µmol ATP, 15 µmol MgCl2, 2 µmol threonine,
2 µmol valine and 2 µmol S-adenosyl-methionine (SAM). For aryl-
peptide synthesis, the reaction mixture further contained 2 µmol p-toluic
acid, 0.8 µmol ACMS I and 1.6 µmol AcmACP. For 14C-labelling,
1.5 µCi of amino acids, 0.5 µCi of SAM or 3 µCi of p-toluic acid were
used. After incubation for 30 min at 30°C, the reaction was stopped
with 1.5 ml of 10% trichloracetic acid (TCA) and proteins were precipi-
tated for 30 min on ice. Proteins were washed first with 2 ml TCA (5%),
then with 2 ml EtOH and then air dried. Peptides were released from
the enzyme by thioester cleavage with 0.4 ml performic acid for 4 h at
20°C, vacuum dried, resuspended in formic acid and directly analyzed
by TLC. Aryl peptides were released from the enzyme with 0.3 ml
NaOH (0.5 M) for 5 min at 20°C. After neutralizing with HCl (0.5 M),
they were extracted twice with 2 ml ethylacetate. In order to detect
spontaneously released aryl-intermediates during enzymatic synthesis,
control reactions were extracted with ethyl acetate omitting TCA pre-
cipitation and thioester cleavage. Extracts were vacuum dried and
resuspended in a small volume of ethylacetate for TLC analysis.
Time course of acyl-peptide formation
14C-valine labelled reaction intermediates were isolated from reaction
mixtures as described above after 2, 3, 5, 7, 10, 15, 30 and 45 min of
incubation. Labelled compounds were separated by TLC (as shown for
t = 30 min in Figure 3) and quantified with a TLC-linear analyser Trace-
master 20 (Berthold).
Thin-layer chromatography and HPLC analysis
Peptides and amino acids were analyzed on silica 60 F254 TLC plates
(Merck) with the solvent system n-propanol/acetic acid/H2O (4:1:1
[vol/vol/vol]); aryl-peptides with the solvent system ethylacetate/
n-Hexan/acetic acid (5:5:1 [vol/vol/vol]). Labelled compounds were
detected by autoradiography, nonlabelled standards with ninhydrin
(amino acids and peptides), UV detection (aryl peptides) or chlorine/
o-tolidin (diketopiperazines). For further HPLC analysis and peptide
hydrolysis, labelled compounds were scraped from silica plates and
extracted with 50% EtOH (amino acids and peptides) or MeOH (aryl-
peptides). Configuration of amino acids, obtained from peptide hydroly-
sis with HCl (8 M) for 20 h at 110°C, was determined on TLC chiral
plates (Macherey-Nagel) with solvent system MeOH/acetonitrile/H2O
(1:4:1 and 5:3:5 [vol/vol/vol]). For HPLC analysis, about 200–500 cpm
of a labelled compound (not UV-detectable) was mixed with synthetic
standards (UV absorbance of 0.3–0.5 at 205 nm for peptides and
260 nm for aryl-peptides) and applied on a reversed-phase column
(SuperPac Pep-S, Pharmacia). Chromatography was performed at a
flow rate of 0.5 ml/min with solvent A (0.1% trifluoric acid) and solvent
B (acetonitrile with 0.1% trifluoric acid) with the following gradient pro-
files: 5 min, 0% B; 40 min, 20% B; 45 min, 100% B for peptides and
5 min, 0% B; 65 min 55% B; 70 min, 100% B for aryl-peptides. Frac-
tions of 0.5 ml were collected and labelled compounds were identified
by liquid scintillation counting.
Radioisotopes and chemicals
S-adenosyl-L-[methyl-14C] methionine (57 Ci/mol, 25 µCi/ml) and
p-toluic acid [carboxy-14C] (8.3 Ci/mol, 83 µCi/ml) were from Amer-
sham and Sigma, respectively; L-threonine [U-14C] (224 Ci/mol,
250 µCi/ml) and L-valine [U-14C] (227 Ci/mol, 250 µCi/ml) were from
ICN. Authentic dipeptides used as standards were either from Bachem
(Thr–Val) or were synthesized (Thr–D-Val) as described previously [23].
Boc-Thr(OBzl)MeValOMe served as the starting material for the syn-
thesis of the reference peptides Thr–MeVal, cyclo(Thr–MeVal) and
p-toluyl-Thr–MeVal by standard procedures. It was obtained by cou-
pling of Boc-Thr(OBzl)-OH with MeValOMe in the presence of PyBrOP
(Novabiochem). The identities of all compounds were verified by amino
acid analysis and mass spectrometry.
PCR oligonucleotides
PCR primers were: M1: 5′-TCTCCGTCCGGGATATCTTCGAGCAG-
CGCACg-3′; M2: 5′-GCAGGATGAATTCGCATGCCGACGACGTC-
ATTTCTGAAT-3′; M3: 5′-CAACCCGAGGATCCGCTCAGCCGTAT-
CGAT-3′; M4: 5′-TGCGGAATTCGAAGATATCCCGGACGGAGAA-
ACCGAT-3′; M5: 5′-CTCAGCCGCATCGATGTCCTCA-3′; M6:
5′-CGCCTCGAAGATATCGCGCAGGCCCA-3′; M7: 5′-AACTCCG-
TGGTCCAGGAATTCCCGAA-3′; M8: 5′-ACGCGGTGAGCTCCTC-
GGCGACCA-3′; As described above, some primer combinations
resulted in PCR products from which only internal subfragments were
used. Additional restriction sites were used for subcloning.
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Nucleotide sequence accession numbers
The nucleotide sequence of the ACMS II gene (acmB) and the ACMS
III gene (acmC) were assigned GenBank accession numbers
AF047717 and AF204401, respectively.
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